Developing instruments to measure the quality of decisions: Early results for a set of symptom-driven decisions
Introduction
Are patients well-informed before they make fateful medical decisions? To what extent can geographic variation in treatment rates or apparent disparities in health care delivery be explained by warranted variation in patients’ preferences for different health outcomes? There is a consensus growing around the importance of engaging and informing patients in decisions about their care, and around the critical role of patients’ preferences in treatment decisions. The Institute of Medicine has defined patient-centered care as “healthcare that establishes a partnership among practitioners, patients and their families (when appropriate) to ensure that decisions reflect patients’ wants, needs and preferences and that patients have the education and support they need to make decisions and participate in their own care” [1]. Recent consensus efforts among researchers, policymakers, consumers and developers of decision aids as part of creating the IPDAS standards also found strong support for a definition of decision quality (DQ) as “the match between chosen option and features that matter most to the informed patient” [2].
Currently, there are no systematic data regarding how well patients are informed prior to most major medical decisions. Nor are there any data or even well-validated approaches to determine the extent to which treatment decisions match patients’ preferences [3], [4]. Most approaches that attempt to measure the quality of care focus on documenting adherence to evidence-based guidelines, which is appropriate in situations where there is proven, effective care [5], [6]. Wennberg and others have distinguished between “effective-care” decision situations and “preference-sensitive” decisions [7]. The latter is characterized by the presence of more than one medically appropriate option, where the best treatment can only be determined by how an individual weighs the potential benefits and harms. Traditional measures that examine treatment rates alone, or adherence to guidelines, do not provide any information about the quality of decisions in preference sensitive situations. In these situations, it is critical to determine whether the right person is getting matched with the right treatment.
The authors and colleagues have been working on the development of instruments to measure the quality of decisions for preference-sensitive decisions. The first proposal was described by Sepucha et al. [8] and subsequent publications have detailed the conceptual underpinnings of the approach [9] as well as some pilot results [10]. The underlying conceptual framework builds on the systems approach to shared decision making first outlined by Mulley in 1989 [11], [12]. The framework takes a prescriptive approach to decision making and does not require that patients follow the axioms of decision theory, rather it recognizes that factors other than utilities for health states may influence choices, which the authors refer to in this report as “goals and concerns.”
The DQ instruments are designed to measure the extent to which treatments reflect informed patients’ goals and concerns. The instruments are composed of a set of decision-specific knowledge questions and a set of subjective assessments of patients’ goals and concerns. The goals and concerns include good and bad health outcomes, holistic attitudes toward treatments, and the desired influence of others. To be practical, the investigators have hypothesized that a small set of key facts can be reliably identified that are necessary in order for a patient to be considered “informed.” In addition, a small set of goals and concerns can be identified that can be used to calculate the extent to which patients’ goals are met by the chosen treatment [8].
The purpose of this report is to describe the early development work on DQ instruments for a set of similar symptom-driven conditions and to present results from a set of cross-sectional surveys of patients and providers. These conditions include osteoarthritis of the knee (OAKnee) and hip (OAHip), herniated lumbar disc (HD), spinal stenosis (SS) and benign prostatic hyperplasia (BPH). Each of these conditions cause symptoms that compromise quality of life, symptoms may fluctuate over time, and can interfere with daily activities. Surgery is an option for each of these conditions, and offers a high chance of relief, but carries with it a set of harms, including serious risks and problematic side effects. Non-surgical treatments are also available for each condition, and these have fewer possible side effects, but are generally less effective than surgery in relieving symptoms. These are preference-sensitive decisions as the “best” choice depends on how each patient feels about the likelihood and magnitude of the possible symptom relief and about the likelihood and impact of different harms, including the expected timing of the benefits and harms.
As mentioned before, the investigators believe that there are limited set of key facts that patients need to understand in order to be informed and a limited set of goals that are salient for patients and will help distinguish those who may prefer surgical vs. non-surgical treatment. This paper reports evidence on the validity of the methods for identifying those items for inclusion in a decision quality instrument. In particular, it examines the extent to which the process identified items that were accurate, important and complete, and whether or not it was possible to identify a small, core set of items for each condition.
Section snippets
Process for developing instruments to measure decision quality
The development process follows survey research methods [13], [14], [15] and has been adapted following a small pilot [10]. Table 1 outlines the steps that are being implemented across a range of preference-sensitive decision situations in order to develop a robust process that can be replicated for any preference-sensitive decision. Details on the first step in the process are reported in this manuscript.
Topics, response rates and sample
A cross-sectional survey of patients and providers was conducted for the following five preference-sensitive decision topics: herniated disc (HD), spinal stenosis (SS), osteoarthritis of the knee (OAKnee), osteoarthritis of the Hip (OAHip), and benign prostatic hyperplasia (BPH). Table 3 summarizes the demographics for the patient and provider samples for each topic.
We received 182 responses from patients for an average of 36 responses per condition (range 22–45). The overall response rate for
Discussion
The process for identifying facts and goals is robust and replicable across a range of symptom driven conditions. Multiple steps that incorporated feedback from different participants (including patients) resulted in a set of facts and goals that the vast majority of patients and providers found accurate, important, and complete. These results provide strong evidence that these facts and goals have high content or face validity among these samples.
The importance ratings did not help much to
Conclusion
This is the first report on a process to identify key facts and important goals and concerns for patients in preference-sensitive decisions. The process is replicable and was shown to generate accurate, important and complete sets of facts and goals across five symptom-driven, preference-sensitive decisions. Based on these results, the authors and colleagues have moved on to the next step in the development process and drafted multiple choice knowledge items and developed straightforward
Disclosure
Dr. Sepucha, Dr. Barry, and Dr. Mulley and Ms. Uzogara receive salary and/or grant support from the Foundation for Informed Medical Decision Making (FIMDM). Dr. O’Connor has also received grants from FIMDM. FIMDM has a licensing agreement with Health Dialog, a commercial company that markets patient decision aids and health coaching services. Dr. Mulley also receives royalties from Health Dialog, Inc.
Acknowledgements
Dr. Sepucha presented this research at the International Shared Decision Making Conference in Freiberg, Germany. The authors would like to acknowledge the following colleagues who recruited patients for the study, Mary Ann O’Connor from the Dartmouth Institute for Health Policy and Clinical Practice and Patricia Gallagher, Karen Bogen, Carol Cosenza and Rebecca Crow from the Center for Survey Research at University of Massachusetts Boston. The authors would also like to thank the patients and
References (23)
- et al.
Promoting informed decisions about cancer screening in communities and healthcare systems
Am J Prev Med
(2004) - et al.
An approach to measuring the quality of breast cancer decisions
Patient Educ Couns
(2007) - et al.
A frequently used patient and physician-directed educational intervention does nothing to improve primary care of prostate conditions
Urology
(2001) - et al.
The gap between back pain patients’ prior knowledge and scientific knowledge and its evolution after a back school teaching programme: a quantitative evaluation
Patient Educ Couns
(1996) Crossing the quality chasm: a new health system for the 21st century
(2001)- et al.
Developing a quality criteria framework for patient decision aids: online international Delphi consensus process
Brit Med J
(2006) On what basis should the effectiveness of decision aids be judged?
Health Expect
(2003)- et al.
Systems for implementing best practice for a chronic disease: management of osteoarthritis of the hip and knee
Int Med J
(2006) - et al.
Measuring quality in arthritis care: the Arthritis Foundation's Quality Indicator set for osteoarthritis
Arthritis Rheum
(2004) Unwarranted variations in healthcare delivery: implications for Academic Medical Centers
Brit Med J
(2002)
Policy support for patient-centered care: the need for measurable improvements in decision quality
Health Affairs (Project Hope)
Cited by (67)
Developing an Educational and Decision Support Tool for Stage I Lung Cancer Using Decision Science
2023, Annals of Thoracic SurgeryCitation Excerpt :These scales can also be used pre/post exposure to the tool to assess the extent to which the tool impacts objective and subjective knowledge. Value-choice concordance is challenging to measure but important, since the goal of SDM is to support a choice that aligns with both evidence and patient preferences.61,62 Decisional conflict can be measured once or over time to determine whether patients feel more or less conflicted after using a tool.63
Health Literacy in Patients Considering a Left Ventricular Assist Device: Findings From the DECIDE-LVAD Trial
2022, Journal of Cardiac FailureA multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data
2020, American Heart JournalCitation Excerpt :We will use this measure to test knowledge at baseline, 1 month, and 6 months. Value-choice concordance: We will calculate concordance between patients’ values and the treatment they choose according to the validated methods of Sepucha et al.34,35 We will measure this in 2 ways: (1) we will measure the values-clarity subscale of the decision conflict measure (test-retest reliability and Cronbach α > .78, correlated with knowledge, regret, and treatment discontinuance), and (2) we will explore the prevailing value trade-off between “living longer even if it means getting an invasive therapy” versus “not living as long and avoiding an invasive therapy” as this item was able to discriminate between groups. Additionally, we will collect the following secondary outcomes:
A Tool to Assess Patient and Surrogate Knowledge About the POLST (Physician Orders for Life-Sustaining Treatment)Program
2019, Journal of Pain and Symptom ManagementCaregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial
2018, JACC: Heart FailureCitation Excerpt :As such, coprimary endpoints were chosen comprising the 2 main International Patient Decision Aid Standards domains of decision quality-knowledge and values-choice concordance. A 10-item knowledge test was developed by the study team and validated by clinicians, patients, and caregivers consistent with methods of Sepucha (20). Improvement in knowledge from baseline to post-education was a coprimary endpoint (21).